TME Pharma NV
PAR:ALTME
TME Pharma NV
PAR:ALTME
Price:
0.0727
EUR
-0.68%
Market Cap:
€6.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
TME Pharma NV
PAR:ALTME
|
DE |
|
A
|
AMEN Properties Inc
OTC:AMEN
|
US |
|
F
|
Fulcrum Metals PLC
LSE:FMET
|
UK |
|
P
|
Pico Far East Holdings Ltd
SWB:PJFB
|
HK |
|
C
|
Companhia Energetica do Rio Grande do Norte Cosern
BOVESPA:CSRN6
|
BR |
Cash Flow Statement
Cash Flow Statement
TME Pharma NV
TME Pharma NV
Currency: EUR
| Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(7)
|
(11)
|
(9)
|
(1)
|
(5)
|
(10)
|
(11)
|
(14)
|
(18)
|
(15)
|
(8)
|
(7)
|
(6)
|
(6)
|
(5)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
3
|
6
|
4
|
(3)
|
1
|
5
|
2
|
2
|
4
|
4
|
2
|
2
|
1
|
1
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
0
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
2
|
(1)
|
(3)
|
(1)
|
0
|
0
|
(0)
|
|
| Cash from Operating Activities |
(4)
N/A
|
(4)
-4%
|
(5)
-23%
|
(4)
+13%
|
(3)
+21%
|
(5)
-53%
|
(9)
-79%
|
(12)
-33%
|
(12)
+1%
|
(12)
+1%
|
(10)
+20%
|
(6)
+42%
|
(5)
+12%
|
(5)
+7%
|
(5)
-3%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
(5)
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
0
N/A
|
0
+14%
|
(0)
N/A
|
(5)
-22 550%
|
(0)
+99%
|
4
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
-110%
|
(0)
-43%
|
(0)
+37%
|
(0)
+58%
|
(0)
-163%
|
(0)
+76%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
(0)
|
4
|
4
|
2
|
10
|
9
|
7
|
7
|
0
|
0
|
1
|
3
|
6
|
6
|
3
|
|
| Net Issuance of Debt |
4
|
3
|
1
|
(0)
|
2
|
6
|
5
|
4
|
7
|
7
|
4
|
(0)
|
(2)
|
(1)
|
2
|
|
| Other |
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
(0)
|
|
| Cash from Financing Activities |
4
N/A
|
8
+116%
|
6
-26%
|
1
-75%
|
13
+794%
|
14
+13%
|
12
-13%
|
12
-7%
|
7
-42%
|
7
+10%
|
5
-36%
|
3
-30%
|
5
+43%
|
6
+21%
|
4
-27%
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
(0)
N/A
|
4
N/A
|
1
-78%
|
(3)
N/A
|
5
N/A
|
9
+95%
|
7
-16%
|
(1)
N/A
|
(6)
-574%
|
(5)
+15%
|
(5)
-3%
|
(2)
+52%
|
(0)
+87%
|
1
N/A
|
(1)
N/A
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(4)
N/A
|
(4)
-4%
|
(5)
-23%
|
(4)
+13%
|
(3)
+20%
|
(5)
-53%
|
(9)
-78%
|
(12)
-32%
|
(12)
+1%
|
(12)
+1%
|
(10)
+20%
|
(6)
+42%
|
(5)
+12%
|
(5)
+7%
|
(5)
-3%
|
|
Switch to:
Switch to:
See Also
Discover More
